Cargando…

Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study

PURPOSE: There are few data regarding the epidemiology of hereditary or familial prostate cancer (PCa) in East Asians, especially in Korean men. Therefore, we evaluated the incidence of familial and hereditary PCa and the relation between socioeconomic status and the incidence of nonsporadic prostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Hwan, Park, Kyung Kgi, Chung, Mun Su, Chung, Byung Ha
Formato: Texto
Lenguaje:English
Publicado: The Korean Urological Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037512/
https://www.ncbi.nlm.nih.gov/pubmed/21344024
http://dx.doi.org/10.4111/kju.2011.52.1.9
_version_ 1782198004250312704
author Lee, Seung Hwan
Park, Kyung Kgi
Chung, Mun Su
Chung, Byung Ha
author_facet Lee, Seung Hwan
Park, Kyung Kgi
Chung, Mun Su
Chung, Byung Ha
author_sort Lee, Seung Hwan
collection PubMed
description PURPOSE: There are few data regarding the epidemiology of hereditary or familial prostate cancer (PCa) in East Asians, especially in Korean men. Therefore, we evaluated the incidence of familial and hereditary PCa and the relation between socioeconomic status and the incidence of nonsporadic prostate cancer (NSPC). MATERIALS AND METHODS: We collected data from all patients who were treated for PCa at our center between November 2009 and January 2010. All patients were either newly diagnosed or had been diagnosed with PCa and seen as outpatients during the study period. RESULTS: In a sample of 218 patients with PCa; 25 (11.5%) were NSPC patients, and 193 (88.6%) were sporadic PCa sporadic prostate cancer (SPC) patients. Overall, 11.5% of the patients had a positive family history. There was one hereditary PCa family (three patients, 1.4%) and 11 familial PCa families (22 patients, 10.1%). Patients were divided into three different age groups. Of these, 18 (9.3%) SPC patients and 6 (24%) NSPC patients were diagnosed with the disease at the age of 55 years or younger (p=0.02). Prostate-specific antigen (PSA) levels in the NSPC group were significantly higher than in the SPC group (7.2±3.2 versus 6.3±4.9 ng/ml, p=0.042). SPC patients had larger waist circumferences than did NSPC patients (p=0.041). There were no significant differences between the SPC and NSPC groups in terms of socioeconomic status, Gleason score, pathological stage, or pathologic Gleason grade. CONCLUSIONS: East Asian NSPC patients are diagnosed at earlier ages than are SPC patients, even though the incidence of NSPC in the East Asian population is lower than in Western men.
format Text
id pubmed-3037512
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-30375122011-02-22 Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study Lee, Seung Hwan Park, Kyung Kgi Chung, Mun Su Chung, Byung Ha Korean J Urol Original Article PURPOSE: There are few data regarding the epidemiology of hereditary or familial prostate cancer (PCa) in East Asians, especially in Korean men. Therefore, we evaluated the incidence of familial and hereditary PCa and the relation between socioeconomic status and the incidence of nonsporadic prostate cancer (NSPC). MATERIALS AND METHODS: We collected data from all patients who were treated for PCa at our center between November 2009 and January 2010. All patients were either newly diagnosed or had been diagnosed with PCa and seen as outpatients during the study period. RESULTS: In a sample of 218 patients with PCa; 25 (11.5%) were NSPC patients, and 193 (88.6%) were sporadic PCa sporadic prostate cancer (SPC) patients. Overall, 11.5% of the patients had a positive family history. There was one hereditary PCa family (three patients, 1.4%) and 11 familial PCa families (22 patients, 10.1%). Patients were divided into three different age groups. Of these, 18 (9.3%) SPC patients and 6 (24%) NSPC patients were diagnosed with the disease at the age of 55 years or younger (p=0.02). Prostate-specific antigen (PSA) levels in the NSPC group were significantly higher than in the SPC group (7.2±3.2 versus 6.3±4.9 ng/ml, p=0.042). SPC patients had larger waist circumferences than did NSPC patients (p=0.041). There were no significant differences between the SPC and NSPC groups in terms of socioeconomic status, Gleason score, pathological stage, or pathologic Gleason grade. CONCLUSIONS: East Asian NSPC patients are diagnosed at earlier ages than are SPC patients, even though the incidence of NSPC in the East Asian population is lower than in Western men. The Korean Urological Association 2011-01 2011-01-24 /pmc/articles/PMC3037512/ /pubmed/21344024 http://dx.doi.org/10.4111/kju.2011.52.1.9 Text en © The Korean Urological Association, 2011 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Seung Hwan
Park, Kyung Kgi
Chung, Mun Su
Chung, Byung Ha
Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title_full Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title_fullStr Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title_full_unstemmed Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title_short Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study
title_sort clinical features of familial or hereditary prostate cancer in korean men: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037512/
https://www.ncbi.nlm.nih.gov/pubmed/21344024
http://dx.doi.org/10.4111/kju.2011.52.1.9
work_keys_str_mv AT leeseunghwan clinicalfeaturesoffamilialorhereditaryprostatecancerinkoreanmenapilotstudy
AT parkkyungkgi clinicalfeaturesoffamilialorhereditaryprostatecancerinkoreanmenapilotstudy
AT chungmunsu clinicalfeaturesoffamilialorhereditaryprostatecancerinkoreanmenapilotstudy
AT chungbyungha clinicalfeaturesoffamilialorhereditaryprostatecancerinkoreanmenapilotstudy